GlassScriptPhysician profile
Eric J Oberdorf
NPI 1053390898
$2,029.46
in general payments reported to CMS, 2019-2025
19 companies · $491 in 2025
The $491 reported for 2025 was more than what 76% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $301 · 2020: $167 · 2021: $256 · 2022: $228 · 2023: $111 · 2024: $476 · 2025: $491.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,078.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,077.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $340.68 | 2019-2025 | Precision7, Tryptyr, Eysuvis |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $252.44 | 2019-2021 | |
| Bausch & Lomb Americas INC. | $204.57 | 2022-2025 | Miebo, Xiidra, Infuse |
| Coopervision INC. | $180.21 | 2019-2025 | Myday Contact Lens, Misight Contact Lens |
| Sun Pharmaceutical Industries INC. | $165.05 | 2019-2024 | Cequa |
| Astellas Pharma US INC | $158.22 | 2024 | Izervay |
| Harrow Eye, LLC | $151.68 | 2024-2025 | Vevye |
| Biotissue Holdings INC. | $93.87 | 2025 | |
| Oyster Point Pharma, INC. | $80.98 | 2022-2023 | Tyrvaya |
| Optovue, INC. | $75.02 | 2020-2021 | |
| Allergan, INC. | $72.37 | 2021-2022 | |
| Optos, INC. | $69.51 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $63.76 | 2020-2022 | |
| Tarsus Pharmaceuticals, INC. | $43.60 | 2024-2025 | Xdemvy |
| Dompe US, INC. | $24.27 | 2020 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Carl Zeiss Meditec Ag | $19.40 | 2020 | |
| Shire North American Group INC | $12.99 | 2019 | |
| Kala Pharmaceuticals, INC. | $11.23 | 2021 | |
| Visioneering Technologies, INC. | $9.61 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Oberdorf listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.